[
    [
        {
            "time": "2018-05-23",
            "original_text": "After Hours Most Active for May 23, 2018: GE, F, BAC, MSFT, ABBV, CFG, INTC, CSCO, DCUD, MDLZ, AAPL, AMAT",
            "features": {
                "keywords": [
                    "Most Active",
                    "GE",
                    "F",
                    "BAC",
                    "MSFT",
                    "ABBV",
                    "CFG",
                    "INTC",
                    "CSCO",
                    "AAPL"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "technology",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "After Hours Most Active for May 23, 2018: GE, F, BAC, MSFT, ABBV, CFG, INTC, CSCO, DCUD, MDLZ, AAPL, AMAT",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-05-23",
            "original_text": "Analysts Expect 10% Gains Ahead For The Holdings of FTHI",
            "features": {
                "keywords": [
                    "Analysts",
                    "Expect",
                    "Gains",
                    "FTHI"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "financial services"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Analysts Expect 10% Gains Ahead For The Holdings of FTHI",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-05-23",
            "original_text": "Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "FDA Approval",
                    "Taltz",
                    "Genital Psoriasis"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-05-23",
            "original_text": "Better Buy: AbbVie Inc. vs. Pfizer Inc.",
            "features": {
                "keywords": [
                    "Better Buy",
                    "AbbVie Inc.",
                    "Pfizer Inc."
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Better Buy: AbbVie Inc. vs. Pfizer Inc.",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]